Clinical Trial ECOGUROE3805-M
Title
CHAARTED: ChemoHormonal Therapy versus Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer
Principal Investigator(s)
John Murray
Details
- Protocol No. ECOGUROE3805-M
- Open Date: 09/17/2008
- Staging: Phase III
- Age Group: Adults
- Scope: National
- Objective: To evaluate the ability of early chemotherapy to improve overall survival in men commencing androgen deprivation for metastatic prostate cancer
- Disease Sites: Prostate
- Therapies: Chemotherapy - cytotoxic; Hormonal Therapy
- Drugs: None Specified
- Participating Institutions: Baptist Hospital; Meharry Medical College
- Secondary Protocol No: E3805
Description
None Provided.
Eligibility
Not provided. Please call for more information.
Learn More
- Call toll-free number: 1-800-811-8480
- Use our Online self–referral form
- Print this page for your doctor
You do not have JavaScript enabled. This site works better with JavaScript turned on.
